This is a listing of public information about active Electronic Cigarette Retailer Licenses in Texas as of 10/23/2022
Texas Smoke Shops are known to carry an assortment of cannabis derived products like Delta 8 and 10 products, as well as THC O, THC P, and several other synthetic cannabinoids not often found in bulk in cannabis concentrates.
*Disclaimer* Not all Smoke Shops sell cigarette / tobacco products, and NOT all cigarette / tobacco stores sell Smoke Shop type products. This is a list of active Electronic Cigarette Retailer Licenses in Texas as of 10/23/2022
Taxpayer Name GREWAL & SON ENTERPRISES, INC. owns the Electronic Cigarette Retailer license for HANDI PLUS #19 which is location number 1, with the taxpayer ID of 12630031305 in HARRIS County
with the address of
16006 BEAUMONT HWY
HOUSTON, TX 77049+1965
with a Electronic Cigarette Retailer permit #21008811 which began on 01/01/2022
In March 2020, FDA finalized the “Required Warnings for Cigarette Packages and Advertisements” rule, establishing 11 new cigarette health warnings, consisting of textual warning statements accompanied by color graphics, in the form of concordant photorealistic images, depicting the negative health consequences of cigarette smoking. These new required warnings depict some of the lesser-known, but serious health risks of smoking.
FDA has also published the “Required Warnings for Cigarette Packages and Advertisements – Small Entity Compliance Guide” to help small businesses understand and comply with the final rule.
Effective Date of Final Rule
On August 10, 2022, the U.S. District Court for the Eastern District of Texas issued an order in the case of R.J. Reynolds Tobacco Co. et al. v. United States Food and Drug Administration et al., No. 6:20-cv-00176, to further postpone the effective date of the “Required Warnings for Cigarette Packages and Advertisements” final rule. The new effective date of the final rule is October 6, 2023. Pursuant to the court order, any obligation to comply with a deadline tied to the effective date is similarly postponed. However, FDA strongly encourages entities to submit cigarette plans (as required by 21 CFR 1141.10(g)) as soon as possible, and no later than December 7, 2022.